Axial and coronal unenhanced thin-slice chest HRCT scans (A and B, respectively) in a 25-year-old male cannabis smoker, showing a large (5 cm) bulla (white arrows), sharply demarcated by a thin wall ...

Emphysema is a chronic lung condition that causes damage to the air sacs, leading to difficulty in breathing, chronic coughing and low oxygen levels. The SSA evaluates it under Listing 3.02 ...

You may experience symptoms such as cough, sleepiness, breathlessness, chest condition, and slow walking with emphysema or bronchitis. A spirometry test is one way to distinguish the type of lung ...

You must go to a doctor to know for sure whether you have COPD. That’s because there are things to consider for a diagnosis. Some people have asthma and COPD at the same time. If you have ...

In the United States, about 4.3% of adults as of 2023 had ever received a diagnosis of COPD, emphysema, or chronic bronchitis. You can get COPD at any age, but it is more likely in middle-aged and ...

Bullous Pemphigoid Market Outlook 2025-2035: The 7 major Bullous Pemphigoid market reached a value of USD 287.1 Million in 2024. Looking forward, IMARC Group expects the 7MM to reach USD 1,618.1 ...

In addition, according to the HP study,5 our patient had a probability of 97% of having a HP. The diagnosis of combined pulmonary fibrosis and emphysema is also robust because of the combination of ...

Sanofi and Regeneron’s blockbuster biologic Dupixent (dupilumab) is poised for yet another label expansion, this time for the rare autoimmune skin disorder bullous pemphigoid (BP). The US Food and ...

Background: Combined pulmonary fibrosis and emphysema (CPFE) commonly coexists with connective tissue diseases (CTD), such as rheumatoid arthritis (RA). However, the risk factors contributing to the ...